The rockefeller university

We report an analysis of the Lambda(0)(b) -> Lambda(+)(c)pi(-)pi(+)pi(-) decay in a data sample collected by the CDF II detector at the Fermilab Tevatron corresponding to 2.4 fb(-1) of integrated luminosity. We reconstruct the currently largest samples of the decay modes Lambda(0)(b) -> Lambda(c)(2595)(+)pi(-) (with Lambda(c)(2595)(+) -> Lambda(+)(c)pi(+)pi(-)), Lambda(0)(b) -> Lambda(c)(2625)(+)pi(-) (with Lambda(c)(2625)(+) -> Lambda(+)(c)pi(+)pi(-)), Lambda(0)(b) -> Sigma(c)(2455)(++)pi(-)pi(-) (with Sigma(c)(2455)(++) -> Lambda(+)(c)pi(+)), and Lambda(0)(b) ->Sigma(c)(2455)(0)pi(+)pi(-) (with Sigma(c)(2455)(0) -> Lambda(+)(c)pi(-)) and measure the branching fractions to the Lambda(0)(b) -> Lambda(+)(c)pi(-) branching fraction. We measure the ration B(Lambda(0)(b) -> Lambda(+)(c)pi(-)pi(+)pi(-))/B(Lambda(0)(b) -> Lambda(+)(c)pi(-)) = 3.04 +/- 0.33(stat)(-0.55)(+0.70)(syst) which is used to derive B(Lambda(0)(b) -> Lambda(+)(c)pi(-)pi(+)pi(-)) = (26.8(-11.2)(+11.9)) x 10(-3).

Inter- and intra-species differences in social behavior and recognition-related hormones and receptors suggest that different distribution and/or expression patterns may relate to social recognition. We used qRT-PCR to investigate naturally occurring differences in expression of estrogen receptor-alpha (ER alpha), ER-beta (ER beta), progesterone receptor (PR), oxytocin (OT) and receptor, and vasopressin (AVP) and receptors in proestrous female mice. Following four 5 min exposures to the same two conspecifics, one was replaced with a novel mouse in the final trial (T5). Gene expression was examined in mice showing high (85-100%) and low (40-60%) social recognition scores (i.e., preferential novel mouse investigation in T5) in eight socially-relevant brain regions. Results supported OT and AVP involvement in social recognition, and suggest that in the medial preoptic area, increased OT and AVP mRNA, together with ER alpha and ER beta gene activation, relate to improved social recognition. Initial social investigation correlated with ERs, PR and OTR in the dorsolateral septum, suggesting that these receptors may modulate social interest without affecting social recognition. Finally, increased lateral amygdala gene activation in the LR mice may be associated with general learning impairments, while decreased lateral amygdala activity may indicate more efficient cognitive mechanisms in the HR mice. (C) 2011 Elsevier Inc. All rights reserved.

The August 2011 Clinical and Translational Science Awards conference "Using IT to Improve Community Health: How Health Care Reform Supports Innovation" convened four "Think Tank" sessions. Thirty individuals, representing various perspectives on community engagement, attended the "Health information technology (HIT) as a resource to improve community health and education" session, which focused on using HIT to improve patient health, education, and research involvement. Participants discussed a range of topics using a semistructured format. This article describes themes and lessons that emerged from that session, with a particular focus on using HIT to engage communities to improve health and reduce health disparities in populations.

The hepatitis C virus (HCV) is a major medical problem with at least 130 million infected individuals worldwide. Over the last decade multiple host factors required for HCV cell entry have been identified, but a detailed understanding of their mechanistic interplay remains elusive. Nonetheless, recent advances in defining species-specific barriers of HCV transmission have allowed the identification of a minimal set of entry factors that are required for HCV infection of rodent cells and has culminated in an animal model that recapitulates HCV entry in vivo. A detailed understanding of the viral uptake pathway is imperative to define new drug targets allowing for more effective intervention against this devastating disease.

We report an indirect search for nonstandard model physics using the flavor-changing neutral current decays B -> K-(*)mu(+)mu(-). We reconstruct the decays and measure their angular distributions, as a function of q(2) = M(mu mu)(2)c(2), where M-mu mu is the dimuon mass, in p (P) over bar collisions at root s = 1.96 Tev using a data sample corresponding to an integrated luminosity of 6.8 fb(-1). The transverse polarization asymmetry A(T)((2)) and the time-reversal-odd charge-and-parity asymmetry A(im) are measured for the first time, together with the K* longitudinal polarization fraction F-L and the muon forward-backward asymmetry A(FB) for the decays B-0 -> K*(0)mu(+)mu(-) and B -> K*(+)mu(+)mu(-). The B -> K*mu(+)mu(-) forward-backward asymmetry in the most sensitive kinematic regime, 1 <= q(2) < 6 GeV2/c(2), is measured to be A(FB) 0.29(-0.23)(+0.20) (stat) +/- 0.07 (syst), the most precise result to date. No deviations from the standard model predictions are observed.

There is growing evidence that functional brain images in alert task-engaged subjects contain task-related but stimulus-independent signals in addition to stimulus-evoked responses. It is important to separate these different components when analyzing the neuroimaging signal. Using intrinsic-signal optical imaging combined with electrophysiology we had earlier reported a particular 'trial-related signal' in the primary visual cortex (V1) of alert monkeys performing periodic fixation tasks. This signal periodically modulated V1 tissue blood volume, in time with anticipated trial onsets. Unlike visually evoked blood volume changes, however, this signal was present even in total darkness. Further, it could not be predicted by concurrently recorded spiking or local field potentials. Here we use our earlier recording techniques to analyze the spatial distribution of this trial-related signal over our imaged area (10 mm square, subdivided into a 16 x 16 grid, i.e. at 625 mu m resolution). We show that the signal is spatially coherent and essentially homogeneous over the imaged region and fails to be predicted by concurrent electrode recordings even at the resolution of a single grid square at the electrode tip. As a corollary we show that the signal is critically linked to the animals' engagement in a task. Not only does the trial-related signal entrain accurately and precisely to any task timing at which the animal was willing to perform: the signal also loses the entrained trial-locked pattern dramatically, within a single trial, when the animal stops performing correctly. Thus the signal is very unlikely to be an ongoing task-independent vascular oscillation. These findings will help categorize the likely distinct varieties of non-stimulus-related signals evoked during behavioral tasks, and lead to a further understanding of the elements comprising the net neuroimaging response. (C) 2011 Elsevier Inc. All rights reserved.

We present an innovative microfluidic approach to transcranial delivery of small quantities of drugs in brief time pulses for neurobiological studies. The approach is based on a two-stage process of consecutive drug dispensing and delivery, demonstrated by a device featuring a fully planar design in which the microfluidic components are integrated in a single layer. This 2-D configuration offers ease in device fabrication and is compatible to diverse actuation schemes. A compliance-based and normally closed check valve is used to couple the microchannels that are responsible for drug dispensing and delivery. Brief pneumatic pressure pulses are used to mobilize buffer and drug solutions, which are injected via a cannula into brain tissue. Thus, the device can potentially allow transcranial drug delivery and can also be potentially extended to enable transdermal drug delivery. We have characterized the device by measuring the dispensed and delivered volumes under varying pneumatic driving pressures and pulse durations, the standby diffusive leakage, and the repeatability in the delivery of multiple pulses of drug solutions. Results demonstrate that the device is capable of accurately dispensing and delivering drug solutions 5 to 70 nL in volume within time pulses as brief as 50 ms, with negligible diffusive drug leakage over a practically relevant time scale. Furthermore, testing of pulsatile drug delivery into intact mouse brain tissue has been performed to demonstrate the potential application of the device to neurobiology. [2011-0130]

In a previous study, steady-state methadone treatment was found to prevent associative cocaine learning, as well as related decreases in mRNA expression of preprohypocretin/preproorexin (ppHcrt) in the lateral hypothalamus (LH) and dopamine D2 receptor (DR2) in the caudate-putamen (CP), and increases in mu-opioid receptor in the ventral striatum of rats. To investigate whether the same regimen of methadone exposure could prevent the incubation of cocaine sensitization and related alterations in gene expression, male Sprague-Dawley rats received 45 mg/kg/day steady-dose "binge" cocaine administration (IP) for 14 days followed by mini-pumps releasing 30 mg/kg/day methadone (SC). After 14 days of methadone, and a subsequent 10-day drug-free period, all rats were tested for sensitization (cocaine test dose: 15 mg/kg) and brain tissue was collected to quantify mRNA expression. Rats exposed to cocaine displayed cocaine-induced stereotypy at test, as well as enhanced ppHcrt mRNA in the LH and reduced DR2 mRNA in the CP. Importantly, these alterations were significantly reduced in rats treated with methadone following cocaine. These results suggest that steady-state methadone can interfere with the incubation of neuroadaptations underlying changes in behavioral responses to cocaine and cocaine-associated stimuli, and that these effects can be observed even after withdrawal from methadone. (C) 2011 Elsevier B.V. and ECNP. All rights reserved.

Mucosal mononuclear (MMC) CCR5+CD4+ T cells of the gastrointestinal (GI) tract are selectively infected and depleted during acute HIV-1 infection. Despite early initiation of combination antiretroviral therapy (cART), gut-associated lymphoid tissue (GALT) CD4+ T cell depletion and activation persist in the majority of HIV-1 positive individuals studied. This may result from ongoing HIV-1 replication and T-cell activation despite effective cART. We hypothesized that ongoing viral replication in the GI tract during cART would result in measurable viral evolution, with divergent populations emerging over time. Subjects treated during early HIV-1 infection underwent phlebotomy and flexible sigmoidoscopy with biopsies prior to and 15-24 months post initiation of cART. At the 2nd biopsy, three GALT phenotypes were noted, characterized by high, intermediate and low levels of immune activation. A representative case from each phenotype was analyzed. Each subject had plasma HIV-1 RNA levels <50 copies/ml at 2nd GI biopsy and CD4+ T cell reconstitution in the peripheral blood. Single genome amplification of full-length HIV-1 envelope was performed for each subject pre- and post-initiation of cART in GALT and PBMC. A total of 280 confirmed single genome sequences (SGS) were analyzed for experimental cases. For each subject, maximum likelihood phylogenetic trees derived from molecular sequence data showed no evidence of evolved forms in the GALT over the study period. During treatment, HIV-1 envelope diversity in GALT-derived SGS did not increase and post-treatment GALT-derived SGS showed no substantial genetic divergence from pre-treatment sequences within transmitted groups. Similar results were obtained from PBMC-derived SGS. Our results reveal that initiation of cART during acute/early HIV-1 infection can result in the interruption of measurable viral evolution in the GALT, suggesting the absence of de-novo rounds of HIV-1 replication in this compartment during suppressive cART.